Close Menu

In PNAS, there's no shortage of clinically oriented research. This paper from senior author Jeremy Nicholson and team use pharmacometabonomics to identify metabolic interactions in humans that depend on their microbiome; they urge an assessment of these microbial communities as "an integral part of pharmaceutical development and of personalized health care." Ian Wilson offers a commentary.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.